Abstract: A sensor for detecting a target pathogen (e.g., a virus or a bacterium) in a specimen is disclosed, which includes at least two sensing units one of which is configured to detect at least one protein (such as a structural protein) associated with the target pathogen and another one is configured to detect at least one genetic component (e.g., an RNA or a DNA segment) associated with that pathogen (e.g., an RNA segment that is unique to that pathogen).

Abstract: A sensor for detecting a target pathogen (e.g., a virus or a bacterium) in a specimen is disclosed, which includes at least two sensing units one of which is configured to detect at least one protein (such as a structural protein) associated with the target pathogen and another one is configured to detect at least one genetic component (e.g., an RNA or a DNA segment) associated with that pathogen (e.g., an RNA segment that is unique to that pathogen).

Abstract: In one aspect, a system for detecting inflammation is disclosed, which includes at least one sensor comprising at least one port for receiving a biological sample, and at least one electrochemical cell in fluid communication with said at least one port for receiving said biological sample, said electrochemical cell comprising at least two electrically conductive electrodes, where at least one of said electrodes is functionalized with at least one probe exhibiting specific binding to at least one inflammation biomarker. The system may further include a circuitry for detecting a redox current flowing through said at least one electrode and/or an electrical impedance across said electrodes in response to interaction of the functionalized electrode with the sample, and generating signals in response to said detection. By way of example, the biological sample can be a subject's blood serum.

Abstract: A sensor for detecting a target pathogen (e.g., a virus or a bacterium) in a specimen is disclosed, which includes at least two sensing units one of which is configured to detect at least one protein (such as a structural protein) associated with the target pathogen and another one is configured to detect at least one genetic component (e.g., an RNA or a DNA segment) associated with that pathogen (e.g., an RNA segment that is unique to that pathogen).

Abstract: The invention describes nucleic acids encoding the Daxx protein, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acids, and antibodies relating thereto. Methods and products for using such nucleic acids and polypeptides also are provided.